Impact of balloon-occluded retrograde transvenous obliteration on management of isolated fundal gastric variceal bleeding

Hepatology Research

Volumn 42, Issue 4, 2012, Pages 385-393

  Akahoshi, Tomohiko ^a,b   Tomikawa, Morimasa ^a   Kamori, Masao ^a   Tsutsumi, Norifumi ^a   Nagao, Yoshihiro ^a   Hashizume, Makoto ^b   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Balloon occluded retrograde transvenous obliteration; Gastric varices; Portal hypertension

Indexed keywords

CYANOACRYLATE; FUROSEMIDE; MONOETHANOLAMINE OLEATE; SPIRONOLACTONE;

ADULT; ARTICLE; ASCITES; BALLOON OCCLUDED RETROGRADE TRANSVENOUS OBLITERATION; ENDOSCOPIC THERAPY; FEMALE; FEVER; FOLLOW UP; GASTRIC ULCER BLEEDING; HEMATURIA; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH FUNDUS; STOMACH HEMORRHAGE; STOMACH VARICES; STOMACH VARICES HEMORRHAGE; SURVIVAL;

EID: 84858841874     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00939.x     Document Type: Article

References (34)

1. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16: 1343-9.
2. Hashizume M, Kitano S, Yamaga H, Koyanagi N, Sugimachi K. Endoscopic classification of gastric varices. Gastrointest Endosc 1990; 36: 276-80.
3. Ryan BM, Stockbrugger RW, Ryan JM. A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology 2004; 126: 1175-89. Review.
4. Seewald S, Mendoza G, Seitz U, Salem O, Soehendra N. Variceal bleeding and portal hypertension: has there been any progress in the last 12months? Endoscopy 2003; 35: 136-44. Review.
5. McCormick PA, O'Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut 2001; 49: 682-5.
6. Gluud LL, Langholz E, Krag A. Meta-analysis: isosorbide-mononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices. Aliment Pharmacol Ther 2010; 32: 859-71. Review.
7. Hashizume M, Akahoshi T, Tomikawa M. Management of gastric varices. J Gastroenterol Hepatol 2011; 26 (Suppl 1): 102-8.
8. Korula J, Chin K, Ko Y, Yamada S. Demonstration of two distinct subsets of gastric varices: observations during a seven-year study of endoscopic sclerotherapy. Dig Dis Sci 1991; 36: 303-9.
9. Trudeau W, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc 1986; 32: 264-8.
10. Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 1996; 11: 51-8.
11. Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol 2001; 12: 327-36.
12. Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunt. Surgery 2001; 129: 414-20.
13. Akahoshi T, Hashizume M, Tomikawa M etal. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. J Gastroenterol Hepatol 2008; 23: 1702-9.
14. Arai H, Abe T, Shimoda R, Takagi H, Yamada T, Mori M. Emergency balloon-occluded retrograde transvenous obliteration for gastric varices. J Gastroenterol 2005; 40: 964-71.
15. Hiraga N, Aikata H, Takaki S etal. The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration. J Gastroenterol 2007; 42: 663-72.
16. Akahoshi T, Hashizume M, Shimabukuro R etal. Long-term result of endoscopic histoacryl injection sclerotherapy for gastric variceal bleeding. Surgery 2002; 131: S177-81.
17. Kumar A, Singh S, Madan K, Garg PK, Acharya SK. Undiluted N-butyl cyanoacrylate is safe and effective for gastric variceal bleeding. Gastrointest Endosc 2010; 72: 721-7.
18. Hassab MA. Gastroesophageal decongestion and splenectomy in the treatment of esophageal varices in bilharzial cirrhosis: further studies with a report on 355 operations. Surgery 1967; 61: 169-76.
19. Hashizume M, Kitano S, Yamaga H, Sugimachi K. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant. Lancet 1988; 2: 340-1.
20. Tajiri T, Yoshida H, Obara K etal. General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc 2010; 22: 1-9.
21. de Franchis R, Baveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53: 762-8.
22. Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 2001; 33: 1060-4.
23. Huang YH, Yeh HZ, Chen GH etal. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc 2000; 52: 160-7.
24. Procaccini NJ, Al-Osaimi AM, Northup P, Argo C, Caldwell SH. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. Gastrointest Endosc 2009; 70: 881-7.
25. Watanabe K, Kimura K, Matsutani S, Ohto M, Okuda K. Portal hemodynamics in patients with gastric varices: a study in 230 patients with esophageal and/or gastric varices using portal vein catheterization. Gastroenterology 1988; 95: 434-40.
26. Kameda N, Higuchi K, Shiba M etal. Management of gastricfundalvarices without gastro-renal shunt in 15 patients. World J Gastroenterol 2008; 14: 448-53.
27. Azoulay D, Castaing D, Majno P etal. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 2001; 35: 590-7.
28. Tripathi D, Therapondos G, Jackson E, Redhead DN, Hayes PC. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut 2002; 51: 270-4.
29. Clark W, Hernandez J, McKeon B etal. Rosemurgy Surgical shunting versus transjugular intrahepatic portasystemic shunting for bleeding varices resulting from portal hypertension and cirrhosis: a meta-analysis. Am Surg 2010; 76: 857-64.
30. Tomikawa M, Hashizume M, Saku M, Tanoue K, Ohta M, Sugimachi K. Effectiveness of gastric devascularization and splenectomy for patients with gastric varices. J Am Coll Surg 2000; 191: 498-503.
31. Kim T, Shijo H, Kokawa H etal. Risk factors for hemorrhage from gastric fundal varices. Hepatology 1997; 25: 307-12.
32. Arakawa M, Masuzaki T, Okuda K. Pathology of fundic varices of the stomach and rupture. J Gastroenterol Hepatol 2002; 17: 1064-9.
33. Akahane T, Iwasaki T, Kobayashi N, Tanabe N, Takahashi N, Gama H. Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration. Am J Gastroenterol 1997; 92: 1026-30.
34. Miyamoto Y, Oho K, Kumamoto M, Toyonaga A, Sata M. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension. J Gastroenterol Hepatol 2003; 18: 934-42.